Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Masimo

< Previous 1 2 3 4 5 Next >
New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine
From Masimo
Via Business Wire
Tickers MASI
Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients
From Masimo
Via Business Wire
Tickers MASI
Masimo and Clinton Foundation Host Roundtable Addressing Overdose and Addiction Crisis
From Masimo
Via Business Wire
Tickers MASI
Masimo Expands Into the Personalized Hearables Market with Denon PerL™ True Wireless Earbuds, Featuring Masimo Adaptive Acoustic Technology™ (AAT™)
From Masimo
Via Business Wire
Tickers MASI
Community Health System Expands Use of Multiple Masimo Technologies, System-wide
From Masimo
Via Business Wire
Tickers MASI
Masimo to Present in Jefferies Healthcare Conference
From Masimo
Via Business Wire
Tickers MASI
Masimo Announces FDA 510(k) Clearance of Radius VSM™
From Masimo
Via Business Wire
Tickers MASI
Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment
From Masimo
Via Business Wire
Tickers MASI
Masimo Board of Directors Sets the Record Straight on False and Misleading Claims
From Masimo
Via Business Wire
Tickers MASI
Masimo Files Investor Presentation Highlighting Track Record of Success, Compelling Strategy, Responsive Governance Changes and Risks Posed by Quentin Koffey’s Agenda
From Masimo
Via Business Wire
Tickers MASI
Masimo Board of Directors Files Definitive Proxy and Issues Letter to Stockholders
From Masimo
Via Business Wire
Tickers MASI
Masimo Announces Major Expansion of the HEOS® Platform
From Masimo
Via Business Wire
Tickers MASI
Orange County Business Journal Names Masimo’s Micah Young CFO of the Year
From Masimo
Via Business Wire
Tickers MASI
Masimo Reports First Quarter 2023 Financial Results
From Masimo
Via Business Wire
Tickers MASI
Cambridge University Hospitals Expands Virtual Care Program with Masimo W1™
From Masimo
Via Business Wire
Tickers MASI
Masimo Stork™ Delivers State-of-the-Art Baby Monitoring to the Home
From Masimo
Via Business Wire
Tickers MASI
Masimo to Report First Quarter 2023 Financial Results After Market Close on Tuesday, May 9
From Masimo
Via Business Wire
Tickers MASI
Masimo Announces FDA Clearance of the Rad-G® with Temperature
From Masimo
Via Business Wire
Tickers MASI
Masimo Opioid Halo™ Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System
From Masimo
Via Business Wire
Tickers MASI
Masimo Unveils the Future of Health Tracking and Smart Wearables with the Pre-Sale Launch of the Freedom™ Smartwatch
From Masimo
Via Business Wire
Tickers MASI
European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring
From Masimo
Via Business Wire
Tickers MASI
New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery
From Masimo
Via Business Wire
Tickers MASI
Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives
From Masimo
Via Business Wire
Tickers MASI
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
From Masimo
Via Business Wire
Tickers MASI
Masimo to Present in 44th Annual Raymond James Institutional Investors Conference
From Masimo
Via Business Wire
Tickers MASI
Masimo Reports Fourth Quarter and Full-Year 2022 Financial Results
From Masimo
Via Business Wire
Tickers MASI
New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy
From Masimo
Via Business Wire
Tickers MASI
Masimo Centroid® Receives Innovative Technology Designation from Vizient
From Masimo
Via Business Wire
Tickers MASI
Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28
From Masimo
Via Business Wire
Tickers MASI
Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)
From Masimo
Via Business Wire
Tickers MASI
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.